108 related articles for article (PubMed ID: 27498210)
61. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
[TBL] [Abstract][Full Text] [Related]
62. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.
Umar NA; Abubakar I; Fordham R; Bachmann M
Int J Tuberc Lung Dis; 2012 Jun; 16(6):835-40. PubMed ID: 22613686
[TBL] [Abstract][Full Text] [Related]
63. Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial.
Viers BR; Lightner DJ; Rivera ME; Tollefson MK; Boorjian SA; Karnes RJ; Thompson RH; O'Neil DA; Hamilton RL; Gardner MR; Bundrick M; Jenkins SM; Pruthi S; Frank I; Gettman MT
Eur Urol; 2015 Oct; 68(4):729-35. PubMed ID: 25900782
[TBL] [Abstract][Full Text] [Related]
64. Resource implications of palliative chemotherapy for ovarian cancer.
Doyle C; Stockler M; Pintilie M; Panesar P; Warde P; Sturgeon J; Oza AM
J Clin Oncol; 1997 Mar; 15(3):1000-7. PubMed ID: 9060539
[TBL] [Abstract][Full Text] [Related]
65. [Procedures' costs related to outpatient chemotherapy treatment of women suffering from breast cancer].
Nobrega CR; Lima AF
Rev Esc Enferm USP; 2014 Aug; 48(4):698-705. PubMed ID: 25338252
[TBL] [Abstract][Full Text] [Related]
66. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
[TBL] [Abstract][Full Text] [Related]
67. The effects of expanded mental health benefits on treatment costs.
Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
[TBL] [Abstract][Full Text] [Related]
68. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
69. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
[TBL] [Abstract][Full Text] [Related]
70. [Expenditure in outpatient department and pharmacy on patients with hypertension and the influence from community health management program].
Jiang B; Li YC; Zhang M; Huang ZJ; Liu Y; Wang LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):248-53. PubMed ID: 26917525
[TBL] [Abstract][Full Text] [Related]
71. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
72. A cost analysis of a community-based support centre for cancer patients and their families in Ireland: the EVeCANs study.
Murphy A; Chu RW; Drummond FJ
Support Care Cancer; 2021 Feb; 29(2):619-625. PubMed ID: 32415384
[TBL] [Abstract][Full Text] [Related]
73. Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial.
McCaffrey N; Cheah SL; Luckett T; Phillips JL; Agar M; Davidson PM; Boyle F; Shaw T; Currow DC; Lovell M
PLoS One; 2023; 18(2):e0282465. PubMed ID: 36854021
[TBL] [Abstract][Full Text] [Related]
74. The economics of cancer care.
Bailes JS
Cancer; 1995 Nov; 76(10 Suppl):1886-7. PubMed ID: 8634979
[TBL] [Abstract][Full Text] [Related]
75. Counting the cost of cancer treatment.
The Lancet Haematology
Lancet Haematol; 2015 Jul; 2(7):e267. PubMed ID: 26688379
[No Abstract] [Full Text] [Related]
76. Finding the health-care expenditure that drives variation in cancer survival.
Rutherford MJ
Lancet Oncol; 2024 Jun; 25(6):684-685. PubMed ID: 38703783
[No Abstract] [Full Text] [Related]
77. Better Outcomes for Lower Costs in Breast Cancer Care: Finding a Way.
Newcomer LN
JAMA Oncol; 2017 Mar; 3(3):309-310. PubMed ID: 27768165
[No Abstract] [Full Text] [Related]
78. Calculating the Costs of Cancer: A Patient and Advocate Perspective.
Tinianov S
J Am Coll Radiol; 2023 Jan; 20(1):8-9. PubMed ID: 36513258
[No Abstract] [Full Text] [Related]
79. Innovations in Cancer Therapies and Rising Costs.
Viale PH
J Adv Pract Oncol; 2017; 8(7):676-677. PubMed ID: 30333930
[No Abstract] [Full Text] [Related]
80. The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.
Iragorri N; de Oliveira C; Fitzgerald N; Essue B
Curr Oncol; 2021 Mar; 28(2):1216-1248. PubMed ID: 33804288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
